EUVIMEDEUVIMED entdecken
Zurückgezogene PublikationOpen Access · CC BY 4.0

RETRACTED: LncRNA SLNCR1 facilitates angiogenesis and tumor growth in melanoma via DNMT1‐mediated epigenetically silencing SPRY2

Ke Li, Lijun Wu, Jingting Jiang

Skin Research and Technology · 2024

DOI: 10.1111/srt.13910 ↗

Kurz gefasst

Zurückgezogene Publikation in der Zeitschrift Skin Research and Technology, 2024. Verfasst von Ke Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow University, Jiangsu Engineering Research Center for Tumor Immunoth…. Hauptthemen laut MEDLINE: Melanoma, DNA (Cytosine-5-)-Methyltransferase 1, RNA, Long Noncoding, Neovascularization, Pathologic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Suzhou People's Livelihood Science and Technology Project, Construction of key clinical specialties for the Suzhou Municipal "Strengthening Health through Science and Education" Funding Project, Hospital Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The malignancy of melanoma is attributed to its pronounced invasiveness, extensive vascularization, and rapid tumor cell growth and metastasis. LncRNA SLNCR1 is closely associated with a variety of aggressive tumors. However, our understanding of SLNCR1 influences on malignant melanoma growth metastasis mechanism especially proangiogenic mechanism remains unclear.

Methods

The expression of SLNCR1 was evaluated in melanoma tissues, adjacent tissues, melanoma cell lines. The abilities of SLNCR1 on proliferation, migration, and angiogenesis of HUVECs were detected by CCK‐8, flow cytometry, and Western blot assays. The association between SLNCR1, DNMT1, and SPRY2 was assessed by ChIP, RIP, and Western blot assays. The effect of SLNCR1 on tumor growth was determined using a xenograft model in nude mice.

Results

SLNCR1 was confirmed to be highly expressed in melanoma tissues and cells. CM from melanoma cells transfected with sh‐SLNCR1 attenuated proliferation, migration, and angiogenesis of HUVECs. Moreover, loss of SLNCR1 hindered tumor growth and metastasis, as evidenced by reduced tumor size and weight, as well as angiogenesis. Mechanistic studies revealed that SLNCR1 silenced SPRY2 expression, likely through enhancing DNMT1‐mediated DNA methylation of SPRY2 promoter.

Conclusion

SLNCR1 is an oncogene that interacts with DNMT1 to mediate SPRY2 methylation, thereby suppressing SPRY2 expression and promoting the angiogenesis and tumor growth in melanoma. SLNCR1 may serve as a potential target for melanoma treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaDNA (Cytosine-5-)-Methyltransferase 1RNA, Long NoncodingNeovascularization, PathologicMembrane ProteinsSkin NeoplasmsCell ProliferationMice, NudeIntracellular Signaling Peptides and ProteinsHumansAnimalsMiceCell Line, TumorEpigenesis, GeneticCell MovementHuman Umbilical Vein Endothelial CellsFemaleGene Expression Regulation, NeoplasticMaleAngiogenesis

Stichwörter der Autor:innen

DNMT1SPRY2angiogenesislncRNA SLNCR1melanoma

Substanzen

DNA (Cytosine-5-)-Methyltransferase 1RNA, Long NoncodingMembrane ProteinsDNMT1 protein, humanIntracellular Signaling Peptides and ProteinsSPRY2 protein, human

Autor:innen und Institutionen

  • Department of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow University, Jiangsu Engineering Research Center for Tumor Immunotherapy, Institute of Cell Therapy, Soochow University, Changzhou, Jiang…
  • Department of Burn and Plastic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, P. R. China.
  • Department of Plastic and Aesthetic Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, P. R. China.

Förderung

  • Suzhou People's Livelihood Science and Technology Project
  • Construction of key clinical specialties for the Suzhou Municipal "Strengthening Health through Science and Education" Funding Project
  • Hospital Research Fund
  • Suzhou Science and Technology Development Project
  • the Special Project of "Technological Innovation" Project of CNNC Medical Industry Co. Ltd
  • Project of State Key Laboratory of Radiation Medicine and Protection, Soochow University
  • CNNC Elite Talent Program

Zitieren

APA

Li, K., Wu, L., & Jiang, J. (2024). RETRACTED: LncRNA SLNCR1 facilitates angiogenesis and tumor growth in melanoma via DNMT1‐mediated epigenetically silencing SPRY2. Skin Research and Technology. https://doi.org/10.1111/srt.13910

Vancouver

Li K, Wu L, Jiang J. RETRACTED: LncRNA SLNCR1 facilitates angiogenesis and tumor growth in melanoma via DNMT1‐mediated epigenetically silencing SPRY2. Skin Research and Technology. 2024. doi:10.1111/srt.13910

BibTeX
@article{Li2024,
  author = {Li, Ke and Wu, Lijun and Jiang, Jingting},
  title = {RETRACTED: LncRNA SLNCR1 facilitates angiogenesis and tumor growth in melanoma via DNMT1‐mediated epigenetically silencing SPRY2},
  journal = {Skin Research and Technology},
  year = {2024},
  doi = {10.1111/srt.13910}
}
Kostenlos starten →